A major fire broke out at a building inside Terminal Gate 1 of the Serum Institute of India (SII) in Maharashtra’s Pune on Thursday afternoon. As per news agency ANI, 10 fire tenders were engaged to bring the flames at the Serum Institute of India’s Manjari premises under control. However, the latest reports suggest that fire continues to rage on the fourth and fifth floors of SEZ3 building inside Terminal Gate 1 of the SII.

Fire tenders are tackling the inferno at the Serum Institute of India’s campus in Manjari, Pune. The production of the COVID-19 vaccine Covishield, a version of the Oxford/AstraZeneca vaccine, will not be affected, as the fire broke out at a different unit of the pharmaceutical company.


Meanwhile, news agency PTI has reported that the Covishield vaccine is made at the Manjari facility. However, other media reports suggest that the blaze reportedly broke out at an under-construction plant at the SII, which means there would be no effect on the production of the coronavirus vaccine.

CM Uddhav Thackeray is in touch with Pune Municipal Commissioner and has directed state machinery to coordinate & ensure that situation is under control.


10 fire tenders present at Serum Institute of India in Pune, where a fire broke out at Terminal 1 gate.


The covid vaccine is not manufactured where the fire has been reported. Rotavirus vaccine and BCG vaccine is manufactured at the facility, says the government. It will take over an hour to control the blaze, says fire officer. Not much damage at the area where vaccine is manufactured.

Fire broke out at Manjri plant. Production wasn’t done there but the preparation was on to begin it at a later stage. Fire fighting op is on, building has been vacated but we’re re-checking. Fire will be doused in an hr. No problem at vaccine plant/storage: Pune Police Commissioner



Please enter your comment!
Please enter your name here